Hormone Health Guide

Understanding Your Hormones: The Master Regulators of Health

Hormones are chemical messengers that regulate nearly every physiological process in your body — from metabolism and mood to muscle mass, bone density, and cognitive function. When even one hormone drifts outside its optimal range, the downstream effects can be profound, often mimicking other conditions and leading to years of misdiagnosis.

This guide provides a comprehensive, evidence-based framework for understanding hormone health. Whether you're a man experiencing unexplained fatigue, a woman navigating perimenopause, or anyone trying to decode confusing lab results, you'll find actionable information grounded in current endocrinology research and clinical guidelines from the Endocrine Society, the American Thyroid Association (ATA), and the North American Menopause Society (NAMS).

Key insight: Hormones don't operate in isolation. Thyroid dysfunction affects testosterone. Cortisol dysregulation impairs thyroid conversion. SHBG changes alter how much testosterone and estrogen are bioavailable. Understanding these connections is what separates effective treatment from symptom chasing.

Signs of Low Testosterone in Men

Testosterone deficiency (hypogonadism) affects an estimated 20-40% of men over 45, yet the majority remain undiagnosed. The Endocrine Society's 2018 clinical practice guidelines define testosterone deficiency as total testosterone consistently below 300 ng/dL combined with symptoms — but many men experience meaningful symptoms well above this threshold.

Classic Symptoms of Low Testosterone

• Fatigue and reduced vitality — not just tiredness, but a pervasive lack of drive and energy that doesn't improve with sleep
• Reduced muscle mass and strength — difficulty maintaining muscle despite consistent training
• Increased body fat — particularly visceral abdominal fat, which further suppresses testosterone via aromatase activity
• Low libido and erectile dysfunction — often the symptom that finally prompts testing
• Cognitive decline — brain fog, difficulty concentrating, impaired memory
• Mood changes — irritability, depressed mood, reduced motivation
• Sleep disturbances — both poor sleep quality and sleep apnea (which further suppresses testosterone)
• Decreased bone mineral density — testosterone is critical for bone health in men

Why Total Testosterone Alone Is Misleading

Approximately 98% of circulating testosterone is bound — either tightly to sex hormone-binding globulin (SHBG) or loosely to albumin. Only free testosterone (about 2-3% of total) is bioavailable and able to activate androgen receptors. A man with a total testosterone of 550 ng/dL but elevated SHBG may have less bioavailable testosterone than someone with a total of 400 ng/dL and low SHBG.

Testosterone in Women

Women produce testosterone too — about 1/10th to 1/20th of male levels — and it plays critical roles in libido, energy, bone density, and cognitive function. Testosterone deficiency in women is vastly underdiagnosed because most standard panels don't include it, and the reference ranges used by many labs are unreliable at low concentrations.

Optimal total testosterone for premenopausal women is typically 15-70 ng/dL, with free testosterone of 1.0-6.5 pg/mL. Post-menopausal women who report loss of libido, persistent fatigue, or loss of muscle tone despite adequate estrogen therapy may benefit from testosterone assessment using a sensitive assay (LC-MS/MS).

Thyroid Problems: Why TSH Alone Isn't Enough

Thyroid dysfunction is one of the most common — and most commonly missed — endocrine disorders. The standard screening approach of testing only TSH (thyroid-stimulating hormone) misses a significant percentage of thyroid problems because it assumes that the hypothalamic-pituitary-thyroid axis is functioning normally and that T4-to-T3 conversion is adequate.

Understanding Thyroid Physiology

The thyroid gland produces primarily T4 (thyroxine), which is a storage hormone. T4 must be converted to T3 (triiodothyronine) — the active form — by deiodinase enzymes in peripheral tissues. This conversion requires adequate selenium, zinc, and iron, and is impaired by cortisol excess, inflammation, caloric restriction, and certain medications.

When TSH Is Normal But You Still Feel Hypothyroid

Several clinical scenarios produce hypothyroid symptoms despite a "normal" TSH (0.45-4.5 mIU/L on most lab ranges):

• Poor T4-to-T3 conversion — TSH may be normal because T4 is adequate, but active T3 is low
• Elevated reverse T3 (rT3) — stress, illness, and caloric restriction shift conversion toward inactive rT3
• Hashimoto's thyroiditis — autoimmune inflammation causes fluctuating thyroid output; TPO antibodies can be elevated for years before TSH becomes abnormal
• Central hypothyroidism — pituitary dysfunction produces inappropriately normal TSH despite low thyroid hormones
• Suboptimal TSH within reference range — a TSH of 3.5 mIU/L is "normal" but may reflect early thyroid failure in someone whose personal setpoint is 1.2

Thyroid Marker	Standard Reference Range	Optimal Functional Range	Clinical Significance
TSH	0.45–4.5 mIU/L	0.5–2.0 mIU/L	Pituitary signal; elevated = gland underperforming
Free T4	0.8–1.8 ng/dL	1.1–1.5 ng/dL	Storage hormone; shows gland output
Free T3	2.3–4.2 pg/mL	3.0–4.0 pg/mL	Active hormone; shows conversion efficiency
Reverse T3	8–25 ng/dL	<15 ng/dL	Elevated = conversion blockade (stress, inflammation)
TPO Antibodies	<35 IU/mL	<9 IU/mL	Elevated = autoimmune thyroid disease (Hashimoto's)
Thyroglobulin Ab	<40 IU/mL	<4 IU/mL	Second marker for Hashimoto's; sometimes positive when TPO is negative

Clinical pearl: The American Thyroid Association acknowledges that the upper limit of "normal" TSH remains controversial. The 2012 ATA guidelines note that 95% of healthy individuals without thyroid disease have a TSH below 2.5 mIU/L. Many endocrinologists now treat symptomatic patients with TSH above 2.5, particularly if antibodies are positive.

Understanding Cortisol Dysregulation

Cortisol — often mischaracterized as simply the "stress hormone" — is essential for life. It regulates blood sugar, blood pressure, immune function, and the sleep-wake cycle. Problems arise when cortisol rhythms become disrupted: either chronically elevated (Cushing's pattern), chronically low (adrenal insufficiency), or — most commonly — dysregulated in pattern (high at night, low in the morning).

The HPA Axis and Chronic Stress

The hypothalamic-pituitary-adrenal (HPA) axis governs cortisol production. Under chronic stress, this axis can become dysregulated in predictable stages:

1. Stage 1 — Elevated cortisol: High output, often with disrupted diurnal rhythm. Symptoms: anxiety, insomnia, weight gain (especially abdominal), elevated blood sugar, impaired immunity.
2. Stage 2 — Mixed pattern: Cortisol may be high at some times and low at others. The body struggles to maintain appropriate rhythms. Symptoms: wired-but-tired feeling, energy crashes, afternoon fatigue followed by second wind at night.
3. Stage 3 — Low cortisol output: HPA axis downregulation results in blunted cortisol response. Symptoms: profound fatigue, inability to handle stress, orthostatic hypotension, salt cravings, slow recovery from illness or exercise.

How Cortisol Disrupts Other Hormones

Cortisol dysregulation has far-reaching effects on the endocrine system:

• Thyroid: Elevated cortisol inhibits TSH secretion and impairs T4-to-T3 conversion, increasing reverse T3
• Testosterone: Cortisol and testosterone are inversely related. Chronic cortisol elevation suppresses GnRH, reducing LH and downstream testosterone production
• Progesterone: Under stress, the body preferentially converts pregnenolone to cortisol rather than progesterone ("pregnenolone steal" — a simplified model, but clinically observed)
• Insulin: Cortisol promotes gluconeogenesis and insulin resistance, driving metabolic dysfunction

Testing Cortisol Properly

A single morning serum cortisol is a poor screening tool because cortisol fluctuates dramatically throughout the day. The gold standard for assessing HPA axis function is a 4-point salivary cortisol test (or DUTCH urine test), measuring cortisol upon waking, mid-morning, afternoon, and evening. This reveals the cortisol curve — far more informative than any single value.

Perimenopause and Menopause: What's Actually Happening

Perimenopause — the transition period before menopause — typically begins in the mid-40s but can start as early as the late 30s. It is defined by irregular ovarian function, not by the absence of periods. Many women experience significant symptoms for 4-8 years before their final menstrual period.

The Hormonal Shifts of Perimenopause

Contrary to popular belief, perimenopause does not begin with a simple decline in estrogen. The early perimenopausal transition is characterized by:

• Erratic estrogen fluctuations — estrogen can spike to levels higher than normal reproductive years before crashing. These swings — not low estrogen — drive many early symptoms.
• Declining progesterone — as ovulation becomes less consistent, progesterone drops first. This creates a relative estrogen excess even as overall estrogen trends downward.
• Rising FSH — as ovarian reserve declines, FSH increases in an attempt to stimulate follicle development. FSH >25 IU/L on day 3 suggests diminished ovarian reserve.
• Testosterone decline — ovarian testosterone production decreases by approximately 50% between ages 20 and 40, contributing to reduced libido and energy.

Symptoms by Phase

Phase	Typical Duration	Hormonal Pattern	Common Symptoms
Early Perimenopause	2-4 years	Erratic estrogen, low progesterone, normal-high FSH	Shorter cycles, heavier bleeding, breast tenderness, anxiety, insomnia, PMS intensification
Late Perimenopause	1-3 years	Declining estrogen, absent progesterone, high FSH	Skipped periods, hot flashes, night sweats, vaginal dryness, joint pain, brain fog
Menopause (post-final period)	Permanent	Low estrogen (<30 pg/mL), absent progesterone, high FSH (>40)	Vasomotor symptoms (80% of women), genitourinary syndrome, bone loss acceleration, cardiovascular risk increase

NAMS position (2022): Hormone therapy remains the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause. For women under 60 or within 10 years of menopause onset, the benefits of HRT generally outweigh the risks. The "timing hypothesis" — starting HRT early provides cardiovascular protection — is supported by the WHI reanalysis and subsequent studies.

Estrogen Dominance: A Functional Concept

Estrogen dominance refers to an imbalance in the estrogen-to-progesterone ratio — not necessarily absolute estrogen excess. It commonly occurs in early perimenopause (when progesterone drops first), with obesity (adipose tissue produces estrogen via aromatase), with environmental xenoestrogen exposure, or with impaired estrogen detoxification (sluggish liver methylation).

Symptoms of relative estrogen excess include: heavy or prolonged periods, fibroids, breast tenderness, weight gain (hips and thighs), mood swings, headaches, and fluid retention.

The Complete Hormone Panel: What to Test and When

Most hormone problems are missed because providers test too few markers, test at the wrong time, or rely on overly broad reference ranges. Here's what a comprehensive hormone assessment looks like:

For Men

Biomarker	Standard Range	Optimal Range	Notes
Total Testosterone	264–916 ng/dL	500–900 ng/dL	Draw 7-10 AM fasting; confirm low on 2 occasions
Free Testosterone	5–21 pg/mL	9–25 pg/mL	Equilibrium dialysis preferred over calculated
SHBG	10–57 nmol/L	20–40 nmol/L	High = less bioavailable T; low = metabolic syndrome risk
Estradiol (sensitive)	10–40 pg/mL	20–35 pg/mL	Too high = aromatization; too low = joint/bone issues
LH	1.8–8.6 mIU/mL	3–6 mIU/mL	Low LH + low T = secondary hypogonadism
FSH	1.5–12.4 mIU/mL	2–8 mIU/mL	Elevated = primary testicular failure
DHEA-S	80–560 μg/dL	250–450 μg/dL	Adrenal androgen precursor; declines with age
Prolactin	4–15 ng/mL	4–10 ng/mL	Elevated suppresses GnRH → low testosterone

For Women (Premenopausal)

Biomarker	Standard Range	Optimal Range	Notes
Estradiol	Varies by cycle phase	Follicular: 30-100 pg/mL; Mid-cycle: 100-400; Luteal: 50-250	Draw on day 3 (baseline) or day 19-21 (peak luteal)
Progesterone	>1 ng/mL (luteal)	>10 ng/mL (day 19-21)	Confirms ovulation occurred; low = anovulatory cycle
Total Testosterone	8–60 ng/dL	15–70 ng/dL	LC-MS/MS assay critical for accuracy at low levels
Free Testosterone	0.3–5.2 pg/mL	1.0–6.5 pg/mL	Better symptom correlation than total
DHEA-S	65–380 μg/dL	150–300 μg/dL	Adrenal androgen marker; relates to energy and libido
SHBG	18–144 nmol/L	40–80 nmol/L	Oral contraceptives dramatically raise SHBG
FSH	3.5–12.5 (follicular)	<10 mIU/mL (day 3)	Rising day-3 FSH = diminished ovarian reserve

SHBG: The Hidden Controller of Hormone Balance

Sex hormone-binding globulin (SHBG) is a protein produced by the liver that binds testosterone and estrogen, rendering them biologically inactive. SHBG is one of the most important — and most overlooked — markers in hormone assessment because it determines how much of your total hormone production is actually available to your tissues.

What Raises SHBG

• Oral estrogen (birth control pills, oral HRT) — can raise SHBG 2-4x
• Hyperthyroidism
• Low caloric intake and low body fat
• Aging
• Liver disease (cirrhosis)
• Anticonvulsant medications

What Lowers SHBG

• Insulin resistance and obesity
• Hypothyroidism
• Androgens (testosterone, DHEA)
• PCOS — low SHBG is a hallmark finding
• Growth hormone excess
• Nephrotic syndrome

Clinical significance: A woman with "normal" total testosterone but SHBG of 120 nmol/L (from oral contraceptives) may have almost no bioavailable testosterone — explaining her loss of libido, flat mood, and reduced muscle tone. Switching from oral to transdermal estrogen can reduce SHBG and restore testosterone bioavailability without changing the testosterone level itself.

The Thyroid-Cortisol-Testosterone Axis

These three hormone systems are deeply interconnected, and dysfunction in one almost always affects the others. This is why treating a single hormone in isolation often fails — or creates new problems.

How the Axis Works

• Thyroid → Testosterone: Hypothyroidism increases SHBG production and reduces GnRH pulsatility, lowering bioavailable testosterone. Many men with "low T" actually have subclinical hypothyroidism as the root cause.
• Cortisol → Thyroid: Chronic cortisol elevation inhibits TSH secretion, reduces T4-to-T3 conversion (by inhibiting 5'-deiodinase), and increases reverse T3. Stress-induced hypothyroid symptoms are common but won't respond to levothyroxine alone.
• Cortisol → Testosterone: The HPA axis and HPG (hypothalamic-pituitary-gonadal) axis are mutually inhibitory. High CRH (corticotropin-releasing hormone) directly suppresses GnRH. This is why chronically stressed men develop low testosterone and why overtraining syndrome causes hormonal collapse.
• Testosterone → Cortisol: Adequate testosterone improves stress resilience and cortisol recovery. Low testosterone creates a vicious cycle where impaired stress tolerance leads to more cortisol, which further suppresses testosterone.

How to Read Your Hormone Labs

Understanding your lab results requires more than comparing numbers to reference ranges. Here are the principles that experienced endocrinologists use:

Reference Ranges Are Not Optimal Ranges

Laboratory reference ranges are typically defined as the central 95% of a tested population. This population includes people with undiagnosed illness, obesity, and advancing age. A "normal" result may simply mean you're no worse than the average person in a population where metabolic disease is the norm.

Context Matters More Than Numbers

• Timing: Testosterone peaks at 7-8 AM and can drop 30% by afternoon. A 2 PM draw may read "low" when morning levels are normal.
• Fasting state: Glucose and insulin affect SHBG and testosterone acutely. Always test fasting.
• Cycle day (women): Estradiol, progesterone, FSH, and LH vary dramatically across the menstrual cycle. Day 3 and day 19-21 are standard testing windows.
• Medication effects: Biotin supplements interfere with immunoassay-based thyroid tests (falsely low TSH, falsely high T4/T3). Stop biotin 48 hours before testing.
• Illness and stress: Acute illness suppresses TSH and testosterone (sick euthyroid syndrome). Don't test during illness.

Patterns to Look For

1. High TSH + low free T4 + high antibodies = Hashimoto's hypothyroidism — needs treatment and immune support
2. Normal TSH + low free T3 + high reverse T3 = conversion problem — address stress, nutrient deficiencies, inflammation
3. Low total T + low LH/FSH = secondary hypogonadism — evaluate pituitary, medications, sleep apnea
4. Low total T + high LH/FSH = primary hypogonadism — testicular issue, consider karyotype if young
5. Normal total T + high SHBG + low free T = binding problem — address thyroid, liver, or switch from oral estrogen
6. Low progesterone + irregular cycles + age >38 = early perimenopause — consider cyclic progesterone

Natural Ways to Balance Hormones

Before considering hormone replacement, lifestyle and nutritional interventions can meaningfully shift hormone levels. These approaches have clinical evidence supporting their efficacy:

Sleep: The Non-Negotiable Foundation

Sleep is the single most impactful modifiable factor for hormone health. Testosterone is produced primarily during deep sleep; just one week of 5-hour nights reduces testosterone by 10-15% in young men (JAMA, 2011). Cortisol rhythm depends on consistent sleep-wake timing. Growth hormone secretion occurs almost exclusively during slow-wave sleep.

• Target 7-9 hours of sleep per night with consistent timing (within 30 minutes daily)
• Screen for sleep apnea — prevalence in men with low testosterone is >40%
• Prioritize sleep quality: dark room, cool temperature (65-68°F), no alcohol within 3 hours of bed

Resistance Training

Compound resistance exercises (squats, deadlifts, presses) acutely increase testosterone and growth hormone. More importantly, regular strength training improves insulin sensitivity — which lowers SHBG and increases bioavailable testosterone. The evidence supports 3-4 sessions per week of moderate-to-heavy resistance training. Avoid chronic overtraining, which has the opposite effect via cortisol elevation.

Nutrition for Hormone Optimization

• Adequate protein: 0.7-1.0 g/lb bodyweight supports androgen synthesis and preserves muscle mass
• Dietary fat: Extremely low-fat diets (<20% of calories) reduce testosterone. Include sources of monounsaturated (olive oil, avocado) and saturated fat (eggs, butter) — cholesterol is the precursor to all steroid hormones
• Cruciferous vegetables: DIM (diindolylmethane) and sulforaphane support estrogen detoxification via Phase II liver metabolism
• Zinc-rich foods: Oysters, red meat, pumpkin seeds — zinc is required for testosterone synthesis and thyroid hormone conversion
• Selenium sources: Brazil nuts (1-3 daily provides ~200 mcg), fish, eggs — required for deiodinase enzymes that convert T4 to T3
• Avoid excessive caloric restriction: Prolonged deficits suppress thyroid (T3 drops), testosterone, and reproductive hormones

Stress Management and the HPA Axis

Cortisol-reducing practices with clinical evidence include:

• Mindfulness meditation: 8-week MBSR programs reduce salivary cortisol by 20-25% (Psychoneuroendocrinology, 2017)
• Deep breathing / vagal tone exercises: 5-10 minutes of slow breathing (5.5 breaths/minute) measurably reduces cortisol within 20 minutes
• Nature exposure: 20+ minutes outdoors reduces cortisol (Forest Bathing research, International Journal of Environmental Research, 2019)
• Limiting caffeine: Caffeine after noon extends cortisol half-life and disrupts sleep architecture — the cascading effect impairs overnight testosterone production

Evidence-Based Supplements for Hormone Support

Supplementation can be helpful when specific nutrient deficiencies are contributing to hormone dysfunction. The evidence is strongest for:

Ashwagandha (Withania somnifera)

A systematic review and meta-analysis (Journal of Ethnopharmacology, 2021) found that ashwagandha supplementation (300-600 mg of standardized root extract daily) significantly reduces cortisol, improves testosterone in men, and enhances subjective stress resilience. The best-studied extract is KSM-66 at 600 mg/day. Effects typically manifest within 8-12 weeks.

Zinc

Zinc deficiency is common (estimated 12% of US adults, higher in athletes and vegans) and directly impairs testosterone synthesis. Supplementation (30 mg zinc picolinate or citrate daily) restores testosterone in deficient individuals. Note: long-term zinc supplementation above 40 mg/day can deplete copper — consider a 15:1 zinc-to-copper ratio.

Selenium

Critical for thyroid hormone conversion (T4 → T3) via selenoprotein deiodinases. Also reduces TPO antibodies in Hashimoto's (European Thyroid Journal, 2017). Dose: 200 mcg/day from selenomethionine or 1-3 Brazil nuts daily. Do not exceed 400 mcg/day (toxicity threshold).

Vitamin D

Vitamin D functions more like a hormone than a vitamin. Deficiency (below 30 ng/mL) is associated with lower testosterone, impaired thyroid function, and increased autoimmune thyroid disease. The Endocrine Society recommends maintaining levels of 40-60 ng/mL. Most adults need 2,000-5,000 IU daily to achieve optimal levels; dose based on blood levels, not guesswork.

Magnesium

Involved in 600+ enzymatic reactions, including steroid hormone synthesis and SHBG binding. Magnesium deficiency (common with modern agriculture) increases SHBG, reduces free testosterone, and impairs sleep quality. Dose: 200-400 mg of magnesium glycinate or threonate at bedtime. Glycinate form has the best bioavailability and a calming effect on sleep.

When Hormone Replacement Therapy Makes Sense

Lifestyle optimization has limits. When hormone levels are genuinely deficient — not just suboptimal — and symptoms significantly impair quality of life, hormone replacement therapy (HRT) can be transformative.

Testosterone Replacement in Men

The Endocrine Society (2018) recommends testosterone therapy for men with consistently low total testosterone (<300 ng/dL on two morning measurements) combined with symptoms. Options include:

• Topical testosterone (gel/cream): Daily application, provides stable levels, allows dose titration. First-line for most patients.
• Intramuscular injections (cypionate/enanthate): Weekly or biweekly. Lower cost but creates peaks and troughs unless using subcutaneous microdosing protocols.
• Clomiphene citrate: Off-label for younger men who want to preserve fertility. Stimulates endogenous production by blocking estrogen feedback at the pituitary.

Monitoring requirements: PSA, hematocrit (TRT raises red blood cells), lipids, and estradiol every 3-6 months initially.

Menopause Hormone Therapy (MHT)

NAMS (2022) endorses hormone therapy as first-line for vasomotor symptoms in women under 60 or within 10 years of menopause. Evidence-based options include:

• Transdermal estradiol (patch or gel): 0.025-0.1 mg/day. Preferred over oral because it avoids first-pass liver metabolism, doesn't raise SHBG or clotting factors, and has a more favorable cardiovascular profile.
• Micronized progesterone (Prometrium): 100-200 mg at bedtime for women with a uterus. Oral micronized progesterone has anxiolytic and sleep-promoting effects. Preferred over synthetic progestins (medroxyprogesterone) based on safety data.
• Vaginal estrogen: For genitourinary syndrome of menopause (dryness, painful intercourse, recurrent UTIs). Minimal systemic absorption; safe even in women for whom systemic HRT is contraindicated.
• Testosterone for women: Low-dose transdermal testosterone (300 mcg/day, roughly 1/10th male dose) for hypoactive sexual desire disorder. Supported by international consensus (Global Consensus Statement on Testosterone Therapy for Women, 2019).

Thyroid Hormone Replacement

Standard treatment for hypothyroidism is levothyroxine (T4 monotherapy). However, approximately 10-15% of patients remain symptomatic despite "normalized" TSH. For these patients, the ATA acknowledges that combination T4/T3 therapy (levothyroxine plus liothyronine) or natural desiccated thyroid (NDT, such as Armour Thyroid) may provide benefit — though evidence remains mixed and guidelines recommend individualized trials.

Endocrinologist vs. Functional Medicine: How to Choose

Choosing the right provider depends on your situation:

See a Conventional Endocrinologist When:

• You suspect serious pathology (pituitary tumor, Cushing's disease, Graves' disease, primary adrenal insufficiency)
• You need formal diagnosis for insurance purposes
• You have Type 1 diabetes, thyroid cancer, or other conditions requiring specialist management
• You want established protocols with long-term safety data

Consider Functional or Integrative Medicine When:

• Standard workup is "normal" but you have persistent symptoms
• You want comprehensive testing (full panels, not just screening markers)
• You want to explore root causes before committing to lifelong HRT
• You're interested in combining lifestyle, nutrition, and targeted supplementation
• You want a provider who orders optimal-range interpretation, not just disease-exclusion

Frequently Missed Diagnoses in Hormone Health

Subclinical Hypothyroidism

TSH 2.5-10 mIU/L with normal T4 affects 4-10% of adults. Many providers won't treat until TSH exceeds 10, but symptomatic patients with TSH >4.0 — particularly with positive antibodies — often benefit from low-dose levothyroxine (25-50 mcg). The evidence supports treating this population when symptoms are present (BMJ, 2019 systematic review).

Secondary Hypogonadism from Medications

Opioids, SSRIs, spironolactone, finasteride, and corticosteroids all suppress testosterone through different mechanisms. Many men on chronic opioid therapy have testosterone below 200 ng/dL yet are never tested. Always review the medication list when evaluating low testosterone.

PCOS as a Metabolic Disorder

Polycystic ovary syndrome affects 8-13% of reproductive-age women and is fundamentally an insulin resistance condition that drives excess ovarian androgen production. The diagnostic criteria (Rotterdam) require 2 of 3: oligo/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound. First-line treatment should address insulin resistance (metformin, inositol, low-glycemic nutrition) rather than simply masking symptoms with oral contraceptives.

Relative Adrenal Insufficiency

Patients with chronically blunted cortisol output (not Addison's disease, but HPA axis suppression from chronic stress, previous prednisone use, or pituitary dysfunction) present with profound fatigue, inability to tolerate exercise, salt cravings, and postural lightheadedness. Morning cortisol below 10 mcg/dL warrants further evaluation with an ACTH stimulation test.

Building Your Hormone Health Action Plan

Optimizing hormonal health is not a single intervention — it's a systematic process of testing, identifying root causes, implementing changes, and retesting to verify progress.

1. Get comprehensive baseline labs — use the panels described above, not just screening markers
2. Identify the primary driver — is it cortisol dysregulation, thyroid conversion, SHBG, nutrient deficiency, or genuinely low production?
3. Address foundations first — sleep, nutrition, stress management, exercise, toxic exposure reduction
4. Target specific deficiencies — supplement confirmed deficiencies (vitamin D, zinc, selenium, magnesium) for 8-12 weeks
5. Retest and reassess — repeat labs after 10-12 weeks of lifestyle intervention
6. Consider HRT if indicated — when levels remain low despite optimized foundations, replacement therapy is appropriate and effective
7. Monitor long-term — hormones change with age, stress, and life circumstances. Annual comprehensive testing helps catch drift early

The goal of hormone optimization is not to achieve artificially high numbers — it's to restore hormonal signaling to a level where your body functions as it should: clear thinking, restorative sleep, healthy body composition, stable mood, adequate libido, and resilience to stress. The numbers serve the symptoms, not the other way around.